A5046844345- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Urinary and Genital Oncology Studies
- Renal cell carcinoma treatment
- Healthcare Policy and Management
- Urinary Bladder and Prostate Research
- Pelvic floor disorders treatments
- Urological Disorders and Treatments
- Pediatric Urology and Nephrology Studies
- Health Systems, Economic Evaluations, Quality of Life
- Colorectal Cancer Screening and Detection
- Urologic and reproductive health conditions
- Kidney Stones and Urolithiasis Treatments
- Multiple and Secondary Primary Cancers
- Renal and related cancers
- Urinary Tract Infections Management
- Primary Care and Health Outcomes
- Sexual function and dysfunction studies
- Genital Health and Disease
- Healthcare Operations and Scheduling Optimization
- Ureteral procedures and complications
- Hormonal and reproductive studies
- Pancreatic and Hepatic Oncology Research
- Cardiac, Anesthesia and Surgical Outcomes
Washington University in St. Louis
2010-2020
Baptist Cancer Center
2017-2019
Saint Louis Zoo
2013-2017
Jewish Hospital
2016
Barnes-Jewish Hospital
2016
University of Washington
2015
Cleveland Clinic
2012
University School
2012
University of Michigan–Ann Arbor
2007-2011
Michigan Medicine
2008-2010
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer management options localized, regional, metastatic disease. Recommendations disease monitoring, treatment recurrent disease, systemic therapy castration-recurrent also are included. This article summarizes the Panel's most significant discussions 2016 update guidelines, which include refinement stratification methods new men with high-risk very-high-risk progressive...
Prostate cancer has surpassed lung as the most common in men United States. The NCCN Guidelines for Cancer provide multidisciplinary recommendations on clinical management of patients with prostate based evidence and expert consensus. Panel guidance treatment decisions localized disease is represented this version. Significant updates early include distinction between active surveillance observation, a new section principles imaging, revisions to radiation recommendations. full version these...
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer provide multidisciplinary recommendations the clinical management of patients with prostate cancer. These Insights highlight notable recent updates. Abiraterone acetate is a first-in-class hormonal agent that represents new standard care metastatic castration-recurrent cancer who have previously received docetaxel (category 1 recommendation). also category 2B prechemotherapy setting asymptomatic or...
<h3>Importance</h3>The use of advanced treatment technologies (ie, intensity-modulated radiotherapy [IMRT] and robotic prostatectomy) for prostate cancer is increasing. The extent to which these have disseminated among patients at low risk dying from uncertain.<h3>Objective</h3>To assess the technologies, compared with prior standards traditional external beam radiation [EBRT] open radical observation, men a cancer.<h3>Design, Setting, Patients</h3>Using Surveillance, Epidemiology, End...
The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer. This report highlights notable recent updates. Radium-223 dichloride is a first-in-class radiopharmaceutical that recently received approval treatment symptomatic bone metastases and no known visceral disease. It category 1 recommendation as both first-line second-line option. Panel also revised choice intermittent or continuous androgen deprivation...
Many physicians confronting declining reimbursement from insurers have invested in ambulatory surgery centers, where they perform outpatient surgical and diagnostic procedures. An ownership stake entitles to a share of the facility’s profits self-referrals. This arrangement can create potential conflict interest between physicians’ financial incentives patients’ clinical needs. Our analysis Florida data for five common procedures revealed significant association physician-ownership higher...
Objectives To assess the impact of ambulatory surgery centers ( ASCs ) on rates hospital‐based outpatient procedures and adverse events. Data Sources Twenty percent national sample Medicare beneficiaries. Study Design A retrospective study beneficiaries undergoing between 2001 2010. Health care markets were sorted into three groups—those with ASC s, those without ASCs, where one opened for first time. Generalized linear mixed models used to opening surgery, perioperative mortality, hospital...
An increase in kidney cancer was reported the United States but overall rates may obscure trends age specific groups. We explored whether incidence differs across groups.We ascertained 63,843 incident renal cases SEER (Surveillance, Epidemiology and End Results) registries for 1975 to 2006. Yearly of were calculated stratified by group. Age diagnosis evaluated Poisson regression.From 2006 adjusted increased 238% from 7.4/100,000 17.6/100,000 adults. From 1991 mean at decreased 64.7 62.7...
The cost efficiency gains achieved from moving procedures to ambulatory surgery centers and offices may be mitigated if the quality of surgical care at these facilities is not comparable that hospital. Motivated by this, we assessed short-term morbidity mortality for patients location care.
To evaluate the relationship between ownership and use of ambulatory surgical centers (ASCs).From 1998 through 2002, discharges for procedures within genitourinary system were abstracted from Florida State Ambulatory Surgery Database. State-wide utilization rates surgery calculated by physician-level (using an empirically-derived, externally-validated method) financial incentives. A surgeon-level Poisson regression model was fit to compare year, ownership, their interaction.Rates increased...
As the American population ages, benign prostatic hyperplasia and its associated lower urinary tract symptoms have become increasingly important causes of chronic morbidity. We assessed comparative effectiveness 2 common forms surgical therapy, transurethral prostate resection laser for hyperplasia.Using patient level discharge data revisit files from Agency Healthcare Research Quality we evaluated a cohort patients who underwent or therapy in 2005 California. Short-term outcomes, including...
For patients who experience a localized recurrence after definitive radiation therapy for prostate cancer, salvage prostatectomy provides chance cure. We sought to assess whether robot assistance would decrease the technical challenges and mitigate considerable morbidity associated with procedure.Using institutional data, we identified six underwent robot-assisted therapy. all patients, preoperative postoperative quality of life were measured using Sexual Health Inventory Men Expanded...
Abstract BACKGROUND: Early stage bladder cancer is a heterogeneous disease with variable risk of progression and mortality. Uncertainty surrounding the optimal care for these patients may result in mismatch between treatment intensity. METHODS: Using Surveillance, Epidemiology, End Results‐Medicare data, we identified diagnosed early (n = 24,980) 1993 2002. We measured patients' intensity by totaling all Medicare payments made 2 years after diagnosis. multiple logistic regression, assessed...